Single-walled carbon nanotube biosensor for detection of glucose, lactate, and urea

Patent metadata

Field	Value
Publication number	US-10031102-B2
Application number	US-201414910294-A
Country	US
Kind code	B2
Filing date	Aug 5, 2014
Priority date	Aug 5, 2013
Publication date	Jul 24, 2018
Grant date	Jul 24, 2018

Abstract

A single-walled carbon nanotube-based micron scale multiplex biosensor is provided that enables the detection of glucose, lactate, and urea. The sensor is based on modification of semiconducting single-walled carbon nanotubes using a linker that non-covalently associates with the nanotubes and covalently couples to an enzyme. Reaction of a physiological substrate with the enzyme results in increased resistance of the nanotubes within the sensor. The sensor is suitable for use in patient monitoring, particularly in a clinical setting. Incorporation of read out electronics and an RF signal generator into the sensor device enables it to communicate to a relay station or remote receiver. Methods are also provided for fabricating the biosensor device and using the device for detection.

First claim

The invention claimed is:

1. A microscale multiplex biosensor configured for real time, simultaneous detection of two or more different chemical agents selected from the group consisting of D-glucose, L-lactate, and urea, the biosensor comprising:
a substrate;
a conductive layer attached to a surface of the substrate, the conductive layer forming at least first and second pairs of electrodes with an insulating gap between the electrodes of each pair; and
a first conductive bridge between the first pair of electrodes and a second conductive bridge between the second pair of electrodes, each conductive bridge consisting essentially of one or more functionalized single-walled carbon nanotubes contacting the pair of electrodes and bridging the gap between the pair of electrodes;
wherein the one or more nanotubes of the first conductive bridge are functionalized via a linker with a first enzyme that reacts with a first chemical agent selected from the group consisting of D-glucose, L-lactate, and urea, whereby the conductivity of the first conductive bridge is modified;
wherein the one or more nanotubes of the second conductive bridge are functionalized via a linker with a second enzyme that reacts with a second chemical agent selected from the group consisting of D-glucose, L-lactate, and urea, wherein the second chemical agent is different from the first chemical agent, whereby the conductivity of the second conductive bridge is modified; and
wherein the linker is 1-pyrenebutanoic acid succinimidyl ester.

2. The biosensor of claim 1 , wherein the single-walled carbon nanotubes are semiconducting.

3. The biosensor of claim 1 , further comprising a circuit for receiving and/or processing of an electrical signal from said electrodes.

4. The biosensor of claim 1 , wherein the circuit comprises an amperometry circuit.

5. The biosensor of claim 1 , further comprising a transmitter for sending data obtained by the biosensor to a remote receiver.

6. The biosensor of claim 1 , further comprising a third pair of electrodes and a gap between the electrodes and a third conductive bridge consisting essentially of one or more functionalized single-walled carbon nanotubes, each bridging a gap between the third pair of electrodes;
wherein the one or more nanotubes of the third conductive bridge are functionalized via a 1-pyrenebutanoic acid succinimidyl ester linker with a third enzyme that reacts with a third chemical agent selected from the group consisting of D-glucose, L-lactate, and urea, wherein the third chemical agent is different from the first and second chemical agents, whereby the conductivity of the second conductive bridge is modified.

7. The biosensor of claim 1 that is configured for implantation within a subject and providing continuous or periodic detection of said chemical agent.

8. The biosensor of claim 1 that is configured for accepting a body fluid sample of a subject.

9. The biosensor of claim 8 further comprising one or more microfluidic pathways for presenting said body fluid sample to said functionalized conductive bridge.

10. The biosensor of claim 1 that provides quantification of a level of said chemical agent.

11. The biosensor of claim 1 , wherein reaction of said first chemical agent with said first enzyme results in increased electrical resistance of said first conductive bridge, and wherein reaction of said second chemical agent with said second enzyme results in increased resistance of said second conductive bridge.

Assignees

• Univ Northeastern

Inventors

• Lee Jin Young
• Busnaina Ahmed
• Cho Hanchul
• Somu Sivasubramanian

Classifications

• C12Q1/58

  involving urea or urease · CPC title

• C12Q1/006

  for glucose · CPC title

• C12Q1/54

  involving glucose or galactose · CPC title

• B82Y15/00

  Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

• C12Q1/005

  involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence) · CPC title